US judge rejects Glaxo's Paxil patent, supports another
Pharmaceutical giant GlaxoSmithKline Plc. said that a US judge had ruled one patent related to its top-selling anti-depressant Paxil was invalid, but supported another. Europe's biggest drugmaker,